Insider Shareholders with Direct Ownership of Phathom Pharmaceuticals, Inc. (PHAT)
This section provides a comprehensive overview of the insiders with direct ownership of Phathom Pharmaceuticals, Inc. (PHAT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Phathom Pharmaceuticals, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
> 10% Shareholder |
7,588,000 | 4,916,417 | 3,755,583 $65.4 Million | 38 |
Jan 24, 2024
Reduced 49.65%
|
Terrie Curran
President and Chief Executive |
440,682 | 70,995 | 377,734 $6.58 Million | 15 |
Jul 15, 2024
Reduced 8.22%
|
Azmi Nabulsi
Chief Operating Officer |
244,000 | 878,101 | 240,421 $4.19 Million | 10 |
Jul 15, 2024
Reduced 4.34%
|
Molly Henderson
CFO and CBO |
133,500 | 40,386 | 99,447 $1.73 Million | 18 |
Jul 15, 2024
Reduced 4.17%
|
65,500 | 0 | 65,500 $1.14 Million | 10 |
May 23, 2024
Added 13.82%
|
|
44,500 | 0 | 44,500 $775,190 | 3 |
May 29, 2024
Added 35.97%
|
|
19,500 | 0 | 32,096 $559,112 | 2 |
May 23, 2024
Added 24.65%
|
|
29,298 | 0 | 29,298 $510,371 | 3 |
May 23, 2024
Added 26.38%
|
|
19,500 | 0 | 19,500 $339,690 | 2 |
May 23, 2024
Added 35.0%
|
|
19,500 | 0 | 19,500 $339,690 | 2 |
May 23, 2024
Added 35.0%
|
|
19,500 | 0 | 19,500 $339,690 | 2 |
May 23, 2024
Added 35.0%
|
|
Anthony J. Guzzo
VP, Chief Accounting Officer |
6,000 | 0 | 8,399 $146,310 | 1 |
Jan 19, 2022
Added 41.67%
|